Skip to main content
JLK, Inc. logo

JLK, Inc. — Investor Relations & Filings

Ticker · 322510 ISIN · KR7322510009 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 303 across all filing types
Latest filing 2020-03-13 AGM Information
Country KR South Korea
Listing KO 322510

About JLK, Inc.

https://www.jlkgroup.com/en/

JLK, Inc. is an artificial intelligence company that develops medical and data solutions. The company specializes in AI-driven technologies for the entire stroke treatment cycle, from diagnosis to prognosis. Its flagship platform, MEDIHUB STROKE, is a comprehensive solution that utilizes multi-modality medical imaging analysis (CT, MRI) to provide rapid and precise decision support for both ischemic and hemorrhagic strokes. Beyond its primary focus on stroke care, JLK's MEDIHUB platform also includes solutions for dementia and cancer. The company has also developed MEDIHUB TELE, an AI-powered telemedicine platform for remote consultations, and Hello Data, a data management platform optimized for AI machine learning that serves the medical sector and other industries, including autonomous driving and manufacturing.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by JLK Inspection. It contains the agenda for the annual general meeting, including the approval of financial statements, election of directors, and remuneration limits. While it contains financial data (financial statements), this data is provided as part of the proxy materials for the upcoming shareholder meeting, not as a standalone annual report or earnings release. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2020-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Reference Document' (참고서류) for a General Meeting of Shareholders, specifically detailing the agenda items, proxy solicitation information, and financial statements (balance sheets, income statements, etc.) for the fiscal year ending December 31, 2019. In the context of Korean corporate filings (DART), this type of document is a 'Proxy Solicitation & Information Statement' (위임권유신고서) provided to shareholders to request votes for the upcoming Annual General Meeting. Therefore, it is classified as PSI.
2020-03-13 Korean
주요사항보고서(유형자산양수결정)
Capital/Financing Update Classification · 95% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It details a specific corporate decision regarding the acquisition of tangible assets (real estate) for business expansion. This type of regulatory filing, which discloses significant corporate events or transactions that are not periodic financial reports, falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to company mergers/takeovers) or capital changes.
2020-02-25 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal disclosure of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by JLK Inspection. It details the contract value, the counterparty, and the nature of the supply (AI-based lung disease analysis solution). Since this is a specific regulatory disclosure regarding a business contract and does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2020-02-20 Korean
투자판단관련주요경영사항(전립선 병리영상 분석 솔루션 JDP-01A(의료영상전송장치소프트웨어) 국내 인허가 인증 완료(식약처 품목허가 획득))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (JLK Inspection) announcing the receipt of a medical device certification (JDP-01A) from the Ministry of Food and Drug Safety (MFDS). It follows the standard format for 'Major Management Matters' (주요경영사항) filings in the Korean market, which are used to disclose material corporate events. Since it does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2020-02-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (JLK Inspection) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial events. Since it provides specific financial highlights and reasons for the change rather than being a full report or a simple announcement of a report's availability, it falls under the category of general regulatory filings.
2020-01-28 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.